PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biomedicine, Aarhus University, Aarhus, Denmark.\', \'Medical School, Faculty of health, Aarhus University, Aarhus, Denmark.\', \'Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.\', \'Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.\', \'Department of Clinical Pharmacology, Aarhus University Hospital, Aarhus, Denmark.\', \'Senechaem Ltd., Reading, UK.\', \'Lundbeck Foundation, Copenhagen, Denmark.\', \'Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.\', \'University of Dundee, Dundee, Scotland.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/bcpt.13533
?:hasPublicationType
?:journal
  • Basic & clinical pharmacology & toxicology
is ?:pmid of
?:pmid
?:pmid
  • 33176395
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C0907349_interactsWith_C3885145>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C0907349_interactsWith_C3885145>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all